drugset / Trial / NCT05809700

Injection Therapy for Neuropathic Pain

NCT05809700

Completed 36 enrolled Dove Medical Press Ltd
NaSingle-groupOpen-labelTreatment

Summary

Shoulder, neck, back and temporal pain and herpes zoster pain are neuropathic pain. Preliminary clinical studies have confirmed that injection of freshly prepared HA35 can relieve neuropathic pain. This clinical study is a prospective repeated experiments. The purpose of this study was to verify the effectiveness of HA35 injection therapy.

Timeline

Start
2023-06-01
Primary completion
2023-07-12
Completion
2023-07-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Hyaluronate Other / unclassified 100 mg Other

Indications